✦ LIBER ✦

78 A RANDOMIZED PILOT PHASE II STUDY OF THALIDOMIDE AS ADJUVANT THERAPY IN PATIENT WITH HIGH RECURRENCE RISK HEPATOCELLULAR CARCINOMA

✍ Scribed by M.-C. Ho; R.-H. Hu; C.-M. Ho; C.-N. Chen; K.-J. Chang; P.-H. Lee

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

866 POSTER A phase II study of intravesi

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

MP-19.13: A multicenter, randomized, pha

✍ C. Wood; B. Escudier; L. Lacombe; A. Hoos; R. Gupta; R. Flanigan; R. Figlin; P. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 68 KB

POD-6.02: A Multicenter, Randomized, Pha

✍ S. Tanguay; C. Wood; R. Bukowski; P. Champagne; P. Srivastava; B. Escudier; L. L 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Doxorubicin as an adjuvant following sur

✍ C.Paul Morrow; Brian N. Bundy; Howard D. Homesley; William T. Creasman; Ned B. H 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 533 KB

A phase I/II study of the hypoxic cell s

✍ Ding-Jen Lee; Thomas F. Pajak; Joanne Stetz; Stanley E. Order; Joseph B. Weissbe 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 675 KB

A randomized phase III trial of adjuvant

✍ J. Andersen; M. Andersson; K.W. Andersen; P. Dombemowsky; H.T. Mouridsen; C. Ros 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 300 KB